BridgeBio Pharma, Inc.
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage develop…
Biotechnology
US, Palo Alto [HQ]
Balance Sheet
7 Sheets · From 2023 to 2017Configuration
In Million USD. Margins, Growth Rates In %
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Assets | 98.00 | 464.00 | 631.00 | 703.00 | 1,012.00 | 623.00 | 546.00 | |
|
Current
|
97.00 | 445.00 | 599.00 | 642.00 | 839.00 | 505.00 | 477.00 | |
| Cash And Equivalents | 91.00 | 436.00 | 363.00 | 356.00 | 393.00 | 376.00 | 375.00 | |
| Assets | 98.00 | 464.00 | 631.00 | 703.00 | 1,012.00 | 623.00 | 546.00 | |
| Accounts Receivables (AR) | - - | - - | -2.00 | 2.00 | -19.00 | 15.00 | 15.00 | |
| Inventory | - - | - - | - - | - - | -68.00 | 37.00 | 16.00 | |
| Short Term Investments | - - | - - | 182.00 | 251.00 | 442.00 | 95.00 | 58.00 | |
| Other Current Assets | - - | 2.00 | 22.00 | 35.00 | 101.00 | 21.00 | 24.00 | |
|
Non Current
|
- - | 19.00 | 31.00 | 60.00 | 173.00 | 117.00 | 68.00 | |
| Property, Plant, Equipment (Net) | - - | 1.00 | 5.00 | 36.00 | 45.00 | 25.00 | 19.00 | |
|
Intangible Assets
|
- - | - - | - - | - - | 44.00 | 28.00 | 26.00 | |
| Goodwill | - - | - - | - - | - - | - - | - - | - - | |
| Long Term Investments | - - | 17.00 | 31.00 | 2.00 | 49.00 | 43.00 | 3.00 | |
| Other Non Current Assets | - - | 1.00 | -4.00 | 21.00 | 33.00 | 20.00 | 22.00 | |
| Liabilities | 152.00 | 566.00 | 155.00 | 595.00 | 1,878.00 | 1,867.00 | 1,888.00 | |
|
Current
|
8.00 | 32.00 | 52.00 | 91.00 | 130.00 | 117.00 | 143.00 | |
| Accounts Payable | 1.00 | 16.00 | -4.00 | - - | 2.00 | - - | 2.00 | |
| Short Term Debt | - - | - - | 8.00 | 1.00 | 4.00 | 3.00 | 4.00 | |
| Deferred Revenue | - - | - - | 31.00 | 75.00 | - - | 8.00 | 6.00 | |
| Tax Payable | - - | - - | - - | - - | - - | - - | - - | |
| Other Current Liabilities | 6.00 | 19.00 | 4.00 | 5.00 | 113.00 | 94.00 | 122.00 | |
|
Non Current
|
144.00 | 533.00 | 103.00 | 503.00 | 1,748.00 | 1,750.00 | 1,745.00 | |
| Long Term Debt | - - | 54.00 | 99.00 | 494.00 | 1,726.00 | 1,723.00 | 1,735.00 | |
| Leasing Obligations | - - | - - | 8.00 | 18.00 | 22.00 | 15.00 | 13.00 | |
| Deferred Non Current Tax Liabilities | - - | - - | - - | - - | - - | - - | - - | |
| Other Non Current Liabilities | 144.00 | 479.00 | 3.00 | 9.00 | 22.00 | 26.00 | 9.00 | |
| Equity | -58.00 | -101.00 | 475.00 | 107.00 | -865.00 | -1,244.00 | -1,342.00 | |
| Stockholders' Equity | -58.00 | -163.00 | 408.00 | 57.00 | -870.00 | -1,254.00 | -1,354.00 | |
| Retained Earnings | -61.00 | -170.00 | -440.00 | -888.00 | -1,436.00 | -1,918.00 | -2,560.00 | |
| Common Stock | 3.00 | 6.00 | - - | - - | - - | - - | - - | |
| Preferred Stock | - - | - - | 2.00 | - - | - - | - - | - - | |
| Profit | -30.00 | -130.00 | -260.00 | -483.00 | -639.00 | -493.00 | -643.00 | |
| Dividends | -1.00 | - - | - - | - - | - - | - - | - - | |
| Minority Interest | 3.00 | 62.00 | 67.00 | 49.00 | 4.00 | 9.00 | 11.00 | |
| Other Stockholders' Equity | - - | - - | 845.00 | 946.00 | 566.00 | 663.00 | 1,206.00 | |
| Loss Other Compr. Income | - - | - - | - - | - - | - - | - - | - - |